An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia

Stopped The IDMC recommended to stop the study prematurely due to a lack of efficacy.

Conditions

• Acute Myeloid Leukemia

Interventions

• DRUG: Pracinostat
• DRUG: Placebos
• DRUG: Azacitidine

Sponsor

Helsinn Healthcare SA

Collaborators

• [object Object]